story of the week
Impact of Renin–Angiotensin System Inhibitors on Outcomes in Patients With mRCC Treated With ICIs
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Genitourinary Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors
Clin Genitourin Cancer 2022 Apr 29;[EPub Ahead of Print], PV Nuzzo, E Adib, N Weise, C Curran, T Stewart, D Freeman, AH Nassar, S Abou Alaiwi, Z Bakouny, BA McGregor, TK Choueiri, RK Jain, RR McKay, G SonpavdeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.